Supports designating September 2026 as Sickle Cell Disease Awareness Month to educate about SCD and its treatments.

The resolution expresses support for designating September 2026 as Sickle Cell Disease Awareness Month. It aims to educate communities about sickle cell disease, its complications, and the need for research, early detection, effective treatments, and preventative care. Sickle cell disease affects approximately 100,000 individuals in the United States, with 1,800 to 2,000 babies born with the disease annually. The resolution highlights the importance of raising awareness and improving access to treatments, including the recent FDA approval of gene therapies for SCD.

Supports designating September 2026 as Sickle Cell Disease Awareness Month to educate about SCD and its treatments.

The resolution expresses support for designating September 2026 as Sickle Cell Disease Awareness Month. It aims to educate communities about sickle cell disease, its complications, and the need for research, early detection, effective treatments, and preventative care. Sickle cell disease affects approximately 100,000 individuals in the United States, with 1,800 to 2,000 babies born with the disease annually. The resolution highlights the importance of raising awareness and improving access to treatments, including the recent FDA approval of gene therapies for SCD.